ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TMMG The Mission Marketing Group Plc

78.50
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group Plc LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 78.50 77.00 80.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

The Mission Marketing Share Discussion Threads

Showing 976 to 998 of 1450 messages
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older
DateSubjectAuthorDiscuss
11/3/2016
18:25
I have to say the rating on this share confuses me. They deliver what they say they will each year (in recent times) and despite that we've gone nowhere! Presuming results are once again as promised and the forward statement ok then I am positive we will re-rate at some point. I'm a patient man...I need to be.

IMO.

red_shed2000
11/3/2016
16:07
CLL turning very blue ahead of what I believe must be results v. soon? DYOR etc
qs99
08/3/2016
11:17
A few buy's and chart turning up in the run up to premlims on the 22nd !
cheshire man
03/3/2016
08:36
and CLL now moving up nicely, hope a few of you got in from my post 26 Feb...?
qs99
26/2/2016
12:41
if you like this one, take a look at CLL...results due out in March I believe DYOR
qs99
15/2/2016
11:23
all the forecasts are for eps 5.6p then 6.1 p, very modest rating. Great new clients - Ask, Br Airways, Diageo, BMW, RAC, Siemens etc etc. But continues to be unloved. Patience needed. tempted to top up at 39P
puku
29/1/2016
15:54
Or someone else will come in and snap it up....IMO....
qs99
26/1/2016
12:05
Uopdate last week didn't seem to help much. PE of 6 has got to be one the lowest around. Just needs better PR - does anyone know a good company that can help....
dr biotech
22/1/2016
12:37
defo looks interesting IMO vs its peers.... EV/EBITDA 4.2 is IMO not pushing it!
qs99
22/1/2016
10:07
Thanks db. 60p seems a reasonable target.
penpont
22/1/2016
09:52
Finncap;
The Mission Marketing Group*: Trading update (CORP)
The group has issued a trading update for the year to December 2015. The statement confirms that the group has performed well throughout the second half of the financial year and that recent acquisitions are trading well. As a result, final results will be in line with market expectations. The finnCap forecast is for an adjusted PBT of £6.4m, which implies an H2 adjusted PBT of £4.22m. The statement also confirms that net debt will have increased on the last year-end level as a result of the acquisitions, but that the gearing and debt leverage ratios will be broadly unchanged year-on-year and well within internal targets. Following the statement, our 2016 forecast adjusted PBT remains unchanged at £7.4m. At the current 40p share price, the implied 2016 valuation metrics include EV/EBITDA of 4.2x, a PE of 6.0x and a yield of 3.2%. We view this as good value given the forward growth profile and retain our 60p share price target. Final results are expected on 22 March.
Analyst: Mark Paddon

davebowler
22/1/2016
08:30
Reassuring update. Good to see comment re. further progress in current year too. V lowly valued.
penpont
14/1/2016
11:11
good buying opportunity
mfhmfh
02/1/2016
14:46
Growth mentioned frequently in this part of the business:-
jeff h
22/12/2015
21:50
David Morgan sounding confident though doesn't actually say much:-
jeff h
18/12/2015
13:37
Yes it does look cheap.I'm in.
davebowler
16/12/2015
13:49
Looks UV IMO vs its peers....next RNS may help give it a kick start IMO...
qs99
16/12/2015
12:30
Yes like the look of this and have started to add a few as well...DYOR etc
qs99
16/12/2015
12:08
Agree re: valuation, JH -

and I like that the CERN contract is being handled by two of the group companies - Proof and April6. Cross selling and inter group collaboration is often cited as a potential advantage but I suspect rarely delivers all that it could.

I've bought back in with a small investment today.

DYOR

cliffpeat
16/12/2015
10:15
Looks quite a decent contract win:-
jeff h
16/12/2015
08:20
DB whilst there has been no change in the 2015 forecast, 2016 has been increased to reflect the Chapter acquisition.

2016 Old Pbt £7.0m EPS 6.1p

2016 New Pbt £7.4m EPS 6.6p

A P/E of approx. 6.2 then at the current 41p share price.

Too cheap on the face of it and I've added some this am.

jeff h
15/12/2015
14:51
There has been no change in the broker forecasts - I can't see any reason for this sharp fall. Just illiquid I guess
dr biotech
09/12/2015
16:32
They also announced another deal today - not sure why that wasn't a standard RNS. Perhaps the value is small I'd hope they had not paid a significant amount for a company that has only just formed.

Floor seems to be 40p, I was hoping for better things.

dr biotech
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older

Your Recent History

Delayed Upgrade Clock